Browse studies

Find your next paid study

1 recruiting study matching your filters

TRITON-PN: A Phase 3, Global, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy (hATTR-PN)

The purpose of this study is to: * Determine the efficacy of nucresiran in patients with hATTR-PN by evaluating the effect on neurologic impairment, quality o…

Hereditary Transthyretin-Mediated Amyloidosis With PolyneuropathyhATTR-PN

Alnylam PharmaceuticalsNCT07223203